Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Salupharma
Nieuwegein, Utrecht, Netherlandssalupharma.nl ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Salupharma is a specialty pharmaceutical company based in the Netherlands that focuses on the development, registration, and marketing of medicines for niche markets and unmet medical needs. The company specializes in providing access to essential medications that may not be commercially attractive for larger pharmaceutical firms, particularly in therapeutic areas like endocrinology. In 2020, Salupharma was acquired by Ace Pharmaceuticals to strengthen their combined portfolio of orphan drugs and essential medicines. The company is known for its Salu-branded products, including hydrocortisone and prednisolone formulations, which serve patients with rare or specific medical requirements.
- Therapeutic areas
- EndocrinologyImmunology
- Modalities
- Small molecule
- Industry
- Pharma
Beyond the preview
Go deeper on Salupharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Salupharma.